Filter This View

  • USA v. Alfred Caronia, 09-5006-cr

    Publication Date: 2012-12-05
    Practice Area:
    Industry:
    Court: U.S. Court of Appeals, Second Circuit
    Judge: Before: Raggi, Livingston, and Chin, C.JJ.
    Attorneys: For plaintiff: For Appellee: Douglas Letter and Martin Coffey (Jo Ann M. Navickas, Assistant United States Attorney, Scott R. McIntosh, Attorney, Appellate Division, United States Department of Justice, Anne K. Walsh, Associate Chief Counsel, Office of General Counsel, Food and Drug Division, on the brief), for Loretta E. Lynch, United States Attorney for the Eastern District of New York, Brooklyn, NY.
    for defendant: For Defendant-Appellant: Jennifer L. McCann (Thomas F. Liotti, on the brief), Law Offices of Thomas F. Liotti, Garden City, NY. For Amicus Curiae Washington Legal Foundation: Eric E. Murphy, Jones Day (Michael A. Carvin, Jones Day, Daniel J. Popeo, Richard A. Samp, Washington Legal Foundation, on the brief). For Amicus Curiae The Medical Information Working Group: Joan McPhee, Ropes & Gray LLP (Douglas Hallward-Driemeier, Alan Bennett, Ropes & Gray LLP, and Paul Kalb, Coleen Klasmeier, Sidley Austin LLP, on the brief).
    Case Number: 09-5006-cr

    Cite as: USA v. Alfred Caronia, 09-5006-cr, NYLJ 1202580203588, at *1 (2d Cir., Decided December 3, 2012)Before: Raggi, Livingston, and Chin, C.JJ.p

  • September 26, 2011 | New Jersey Law Journal

    Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

    SUPREME COURT OF NEW JERSEY Pursuant to Rule 1:28-2, the Trustees of the New Jersey Lawyers' Fund for Client Protection (Fund) have reported to the Supreme Court the names of those attorneys

    1 minute read

  • September 21, 2012 | New Jersey Law Journal

    Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

    SUPREME COURT OF NEW JERSEYPursuant to Rule 1:28-2, the Trustees of the New Jersey Lawyers' Fund for Client Protection (Fund) have reported to the Supreme Court the names of tho

    1 minute read

  • May 31, 2011 | The Legal Intelligencer

    Verdict Search's Top Verdicts of 2010

    The Top Verdicts of 2010 as reported by VerdictSearch contains charts of the top verdicts and settlements in Pennsylvania, along with breakout charts of selected verdict categories. Also in

    1 minute read

  • Rosenberg v. Chesapeake Pharmaceutical

    Publication Date: 2012-12-05
    Practice Area:
    Industry:
    Court: U.S. District Court, Eastern District
    Judge: District Judge Denis R. Hurley
    Attorneys: For plaintiff: Attorney for Plaintiff By: Howard B. Leff, Esq., Howard B. Leff, P.C., Garden City, NY.
    for defendant: Attorneys for Defendants By: Wendy J. Mellk, Esq., Kimberly N. Dobson, Esq., Jackson Lewis, LLP, Melville, NY.
    Case Number: 10 CV 2336 (DRH)(WDW)

    Cite as: Rosenberg v. Chesapeake Pharmaceutical, 10 CV 2336 (DRH)(WDW), NYLJ 1202580344712, at *1 (EDNY, Decided August 27, 2012)District Judge Denis R.

  • May 9, 2007 | National Law Journal

    Suits Surge Against Makers of Anti-Psych Drug Seroquel

    Plaintiffs filed more than 350 products liability cases last month in Delaware state court against AstraZeneca Pharmaceuticals L.P. over the anti-psychotic drug Seroquel -- a surge exceeding the to

    1 minute read

  • November 22, 2010 | New Jersey Law Journal

    Ineligible In-House Counsel, Multijurisdictional Practitioners and Pro Hac Vice Attorneys

    Pro hac vice attorneys, in-house counsel, and multijurisdictional practitioners attorneys are subject to the same requirements as licensed members of the New Jersey Bar under a number of Court Rule

    1 minute read

  • July 16, 2012 | The Legal Intelligencer

    Reverse-Payment Settlements in Patent Cases May Restrain Trade

    In a case of first impression, the U.S. Court of Appeals for the Third Circuit held Monday that reverse-payment settlements in pharmaceutical patent cases are prima facie evidence of unreason

    1 minute read

  • July 17, 2012 | The Legal Intelligencer

    Third Circuit Takes Skeptical View of Reverse-Payment Settlements

    In a case of first impression, the U.S. Court of Appeals for the Third Circuit has said reverse-payment settlements in pharmaceutical patent cases are prima facie evidence of unreasonable res

    1 minute read

  • July 19, 2012 | The Legal Intelligencer

    Reverse-payment settlements questioned

    In a case of first impression, the U.S. Court of Appeals for the Third Circuit has said reverse-payment settlements in pharmaceutical patent cases are prima facie evidence of unreasonable res

    1 minute read